PreciseDx
PrivateLast Round
Early Funding
Oct 7, 2026
Total Funding Raised
$53.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PreciseDx is a healthcare technology company that specializes in artificial intelligence-driven pathology diagnostics aimed at enhancing patient outcomes in cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Precision Medicine, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreciseDx Comparables
Compare PreciseDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ataraxis AI | 86% | |
| ArteraAI | 83% | |
| Stratipath | 82% |
PreciseDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 7, 2026 | ||||
| Series B Extension | Jun 18, 2025 | ||||
| Series B | Aug 21, 2024 | ||||
| Series A | Jan 11, 2022 |
Key People
Founding team and executive leadership
PreciseDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GenHenn Capital | Series B Extension, Series B |
| Philips Ventures | Series B Extension |
| Eventide Funds | Series B Extension, Series B |
| IBM Ventures | Series A |
| Hobart Healthcare | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2026
Raised $4M in early funding.
- Aug 21, 2026
Monthly visitors grew 170% MoM, reaching 2.2K.
PreciseDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PreciseDx's valuation, stock price, and market status.
Is PreciseDx a public or private company?
PreciseDx is a private company.
What is the current stock price of PreciseDx?
PreciseDx is a private company, so its shares have no public market price. Caplight tracks PreciseDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PreciseDx worth (valuation)?
Valuation information for PreciseDx is not publicly available.
Can I buy PreciseDx stock?
PreciseDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PreciseDx's last funding round?
PreciseDx's most recent funding round was Early Funding on October 7, 2026.
Who are the main investors in PreciseDx?
Key investors in PreciseDx include Philips Ventures, Eventide Funds.
Will PreciseDx IPO soon?
No public IPO plans have been announced for PreciseDx.
How can I track PreciseDx secondary market activity?
Caplight tracks bids, offers, and trades in PreciseDx's shares on secondary markets.